This regulatory mechanism is pertinent in the context of cardiovascular diseases, as demonstrated by SLC7A11's role in preventing Ang II‐induced cardiac hypertrophy through ferroptosis inhibition.40 This evidence concerns the gene AGT and cardiac hypertrophy.